Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 20/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16370352 | 0.91 | PDE5A (0.57) | PDE5A | |
| SCHEMBL16370368 | 0.90 | PDE5A (0.54) | PDE5A | |
| SCHEMBL16370565 | 0.86 | PDE5A (0.45) | PDE5A | |
| SCHEMBL15121020 | 0.85 | PDE5A (0.56) | PDE5A | |
| SCHEMBL16370287 | 0.81 | PDE5A (0.55) | PDE5A | |
| SCHEMBL9914040 | 0.80 | PDE5A (0.51) | PDE5A | |
| SCHEMBL15111571 | 0.80 | PDE5A (0.57) | PDE5A | |
| SCHEMBL15111599 | 0.78 | PDE5A (0.57) | PDE5A | |
| SCHEMBL9913960 | 0.78 | ADORA3 (0.51) | PDE5A | |
| SCHEMBL16370319 | 0.78 | PDE5A (0.45) | PDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9605008-B2 | Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-03-28 | — | — | US | disclosed |
| US-9605008-B2 | Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-03-28 | — | — | US | disclosed |
| US-9605008-B2 | Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-03-28 | — | — | US | disclosed |
| US-20160145271-A1 | BENZYL-1H-PYRAZOLO[3,4-B]PYRIDINES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-05-26 | — | — | US | disclosed |
| US-20160145271-A1 | BENZYL-1H-PYRAZOLO[3,4-B]PYRIDINES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-05-26 | — | — | US | disclosed |
| US-20160145271-A1 | BENZYL-1H-PYRAZOLO[3,4-B]PYRIDINES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-05-26 | — | — | US | disclosed |
| EP-3019506-A1 | BENZYL-1H-PYRAZOLO[3,4-B]PYRIDINES AND USE THEREOF | Bayer Pharma Aktiengesellschaft (DE) | 2016-05-18 | — | — | EP | disclosed |
| WO-2015004105-A1 | BENZYL-1H-PYRAZOLO[3,4-B]PYRIDINES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2015-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145271-A1 | BENZYL-1H-PYRAZOLO[3,4-B]PYRIDINES AND USE THEREOF | PNPO, PLPBP, CYP4B1 | PDE5A 439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.